46th week of 2017 patent applcation highlights part 8 |
Patent application number | Title | Published |
20170326094 | USES OF BIOACTIVE LIPIDS | 2017-11-16 |
20170326095 | PARENTERAL ESMOLOL FORMULATION | 2017-11-16 |
20170326096 | Selective Targeting of Procoagulant Platelets | 2017-11-16 |
20170326097 | GREEN SYNTHESIS OF REDUCED GRAPHENE OXIDE SILICA NANOCOMPOSITE USING NIGELLA SATIVA SEEDS EXTRACT | 2017-11-16 |
20170326098 | CIS-GNETIN H AND TRANS-GNETIN H AS THERAPEUTIC AGENTS | 2017-11-16 |
20170326099 | METHODS OF TREATING LIVER DISEASES | 2017-11-16 |
20170326100 | COMPOSITION FOR ACTIVATING LONGEVITY GENE | 2017-11-16 |
20170326101 | FORMULATION FOR EFFECTIVE TOCOTRIENOL DELIVERY | 2017-11-16 |
20170326102 | Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery | 2017-11-16 |
20170326103 | LYMPH DIRECTING PRODRUGS | 2017-11-16 |
20170326104 | IRE-1ALPHA INHIBITORS | 2017-11-16 |
20170326105 | MELATONIN-BASED NASAL COMPOSITIONS AND USES THEREOF | 2017-11-16 |
20170326106 | TREATMENT OF AGE RELATED MACULAR DEGENERATION WITH A SMALL ACTIVE CHOROIDAL NEOVASCULARIZATION LESION | 2017-11-16 |
20170326107 | 5-HT6 Receptor Antagonists for Use in the Treatment of Alzheimer's Disease with Apathy as Comorbiity | 2017-11-16 |
20170326108 | COMPOSITIONS AND METHODS FOR REDUCING PRION LEVELS | 2017-11-16 |
20170326109 | Fixed Dose Combination for Pain Relief Without Edema | 2017-11-16 |
20170326110 | SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND LOSARTAN | 2017-11-16 |
20170326111 | Method for anesthetizing a body part, organ, or tissue utilizing an anesthetic comprising tetracaine and a vasoconstrictor | 2017-11-16 |
20170326112 | DENTAL ANESTHETIC COMPRISING TETRACAINE AND A VASOCONSTRICTOR FOR INTRANASAL ADMINISTRATION | 2017-11-16 |
20170326113 | Treatment of Mild and Moderate Alzheimer's Disease | 2017-11-16 |
20170326114 | COGNITIVE FUNCTION | 2017-11-16 |
20170326115 | CHEMICAL COMPOUNDS | 2017-11-16 |
20170326116 | HISTONE DEMETHYLASE INHIBITORS | 2017-11-16 |
20170326118 | Drug treatment of tumors wherein hedgehog/smoothened signaling is utilized for inhibition of apoptosis of tumor cells | 2017-11-16 |
20170326119 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | 2017-11-16 |
20170326120 | METHODS AND COMPOSITIONS FOR ENHANCING CHEMOTHERAPY | 2017-11-16 |
20170326121 | COMPLEXES OF LUMACAFTOR AND ITS SALTS AND DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2017-11-16 |
20170326122 | DECREASING EXPRESSION LEVEL OF APOPTOSIS-RELATED GENES BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | 2017-11-16 |
20170326123 | Throat solution for treatment of cold, flu and sore throat | 2017-11-16 |
20170326125 | MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN | 2017-11-16 |
20170326126 | Pharmaceutical Formulations Containing Cannabidiol and Nicotine for Treating Smokeless Tobacco Addiction | 2017-11-16 |
20170326127 | COMPOSITION AND METHOD FOR TREATMENT OF NEUROPSYCHIATRIC DISORDERS | 2017-11-16 |
20170326128 | Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 | 2017-11-16 |
20170326129 | COMPLEXES OF IVACAFTOR AND ITS SALTS AND DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2017-11-16 |
20170326130 | METHOD TO PREVENT CANCER METASTASIS TO BONE | 2017-11-16 |
20170326131 | METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS | 2017-11-16 |
20170326132 | Method for reducing, inhibiting, and eliminating inflammation and pain with transdermal delivery of iron chelator composition | 2017-11-16 |
20170326133 | METHODS OF TREATING MYELODYSPLASTIC SYNDROME WITH FARNESYLTRANSFERASE INHIBITORS | 2017-11-16 |
20170326135 | METAP2 INHIBITORS AND METHODS OF TREATING OBESITY | 2017-11-16 |
20170326136 | Treatment of Pain | 2017-11-16 |
20170326137 | Autoimmune-Induced Glutamatergic Receptor Dysfunction Methods and Treatments | 2017-11-16 |
20170326138 | NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2017-11-16 |
20170326140 | NOVEL USES | 2017-11-16 |
20170326141 | METHOD OF TREATMENT OF CHRONIC COUGH ADMINISTERING ORVEPITANT IN COMBINATION WITH OTHER THERAPEUTIC AGENTS | 2017-11-16 |
20170326142 | SUBSTITUTED PYRIMIDINES FOR TREATMENT OF ACUTE COUGH, CHRONIC COUGH AND URGE TO COUGH | 2017-11-16 |
20170326143 | NOVEL ANTI-INFLAMMATORY AGENTS | 2017-11-16 |
20170326144 | METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE | 2017-11-16 |
20170326145 | COMPOSITION COMPRISING PHOSPHODIESTERASE TYPE 5 INHIBITOR FOR INHIBITING APOPTOSIS OF NERVE CELLS | 2017-11-16 |
20170326146 | METHODS OF TREATING HEPATITIS B INFECTIONS AND RELATED DOSAGE REGIMES | 2017-11-16 |
20170326148 | PREVENTION OR TREATMENT OF URIC ACID OR GOUT DISEASE | 2017-11-16 |
20170326149 | HYDROXYL PURINE COMPOUNDS AND APPLICATIONS THEREOF | 2017-11-16 |
20170326150 | STABLE POWDER FORMULATION CONTAINING AN ANTICHOLINGERIC AGENT | 2017-11-16 |
20170326151 | Compositions Comprising Finafloxacin And Tris | 2017-11-16 |
20170326152 | Isoxazole Compounds As Inhibitors Of Heat Shock Proteins | 2017-11-16 |
20170326153 | Pharmaceutical Composition Consisting of Ceftaroline Fosamil Acetic Acid Solvate Particles Arginine Particles, Both Having A Specific Particle Size Distribution | 2017-11-16 |
20170326154 | Pre-Operative Composition for Sedation or Analgesia | 2017-11-16 |
20170326155 | NOVEL PHARMACOLOGICAL THERAPY FOR NEUROMUSCULAR CONTRACTURES | 2017-11-16 |
20170326156 | METHODS OF TREATING AND/OR PREVENTING NEURODEVELOPMENTAL DISORDERS (AUTISM) USING AMINOSTEROLS | 2017-11-16 |
20170326157 | CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A INHIBITORS | 2017-11-16 |
20170326158 | Spironolactone Aqueous Compositions | 2017-11-16 |
20170326159 | METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID | 2017-11-16 |
20170326160 | ANTIBACTERIAL USE OF HALOGENATED SALICYLANILIDES | 2017-11-16 |
20170326161 | PHARMACEUTICAL FORMULATIONS FOR TREATING SKIN DISORDERS AND METHODS FOR FABRICATING AND USING THEREOF | 2017-11-16 |
20170326162 | Demineralized Bone Matrix Material having Sphingosine-1-Phosphate or Ceramide-1-Phosphate | 2017-11-16 |
20170326163 | METHODS AND COMPOSITIONS FOR TREATMENT OF DRY EYE AND CORRECTION OF ORGAN DYSFUNCTIONS | 2017-11-16 |
20170326164 | BOVINE MILK OLIGOSACCHARIDES | 2017-11-16 |
20170326165 | USE OF RIBOSE IN FIRST RESPONSE TO ACUTE MYOCARDIAL INFARCTION | 2017-11-16 |
20170326166 | COMPOSITIONS AND METHODS FOR TREATING PITUITARY TUMORS | 2017-11-16 |
20170326167 | Compositions and Methods for Treating an Infection | 2017-11-16 |
20170326168 | 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF | 2017-11-16 |
20170326169 | Advanced functional biocompatible polymeric matrix containing nano-compartments | 2017-11-16 |
20170326170 | METHOD OF TREATING A PATIENT WITH A DISEASE CAUSED BY A PATHOGENIC MECHANISM ASSOCIATED WITH ACCUMLATION OF METHYLGLYOXAL | 2017-11-16 |
20170326171 | ADVANCED FUNCTIONAL BIOCOMPATIBLE POLYMER PUTTY USED AS A HEMOSTATIC AGENT FOR TREATING DAMAGED TISSUE AND CELLS | 2017-11-16 |
20170326172 | Sachet Formulation for Amine Polymers | 2017-11-16 |
20170326173 | BRAIN AND NEURAL TREATMENTS COMPRISING PEPTIDES AND OTHER COMPOSITIONS | 2017-11-16 |
20170326174 | METHODS AND COMPOSITIONS FOR TARGETED CLEAVAGE AND RECOMBINATION | 2017-11-16 |
20170326175 | METHOD FOR INDUCTION OF T CELLS FROM PLURIPOTENT STEM CELLS | 2017-11-16 |
20170326176 | Epithelial Treatment | 2017-11-16 |
20170326177 | PLATELET LYSATE GEL | 2017-11-16 |
20170326178 | STEM CELL MATERIAL AND METHOD OF MANUFACTURING | 2017-11-16 |
20170326179 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS | 2017-11-16 |
20170326180 | Demineralized Bone Matrix Material having Allogenic Sphingosine-1-Phosphate | 2017-11-16 |
20170326181 | Compositions and Methods for Transplantation of Colon Microbiota | 2017-11-16 |
20170326182 | AMNIOTIC MEMBRANE PREPARATIONS AND PURIFIED COMPOSITIONS AND THERAPY FOR SCAR REVERSAL AND INHIBITION | 2017-11-16 |
20170326183 | POSTPARTUM CELLS DERIVED FROM UMBILICAL CORD TISSUE, AND METHODS OF MAKING AND USING THE SAME | 2017-11-16 |
20170326184 | IMMUNE MODULATION | 2017-11-16 |
20170326185 | COMPOSITIONS AND METHODS FOR REDUCING BLOOD ALCOHOL CONTENT | 2017-11-16 |
20170326186 | STRAINS OF LACTOBACILLUS AND BIFIDOBACTERIA FOR THE MAINTENANCE OF A LONG-LASTING HOMEOSTASIS CONDITION IN A HUMAN BODY | 2017-11-16 |
20170326187 | METHOD OF PREPARING MIRABILITUM PRAEPARATUM BY PURE STRAIN FERMENTATION AND ITS APPLICATIONS | 2017-11-16 |
20170326188 | USES OF PORIA COCOS EPIDERMIS EXTRACT, PORICOIC ACID A, AND PORICOIC ACID B IN REGULATING BLOOD GLUCOSE LEVEL | 2017-11-16 |
20170326189 | Process for Obtaining a Composition Enriched with Dihydroquercetin or with Tannins | 2017-11-16 |
20170326190 | GOLD KIWIFRUIT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR | 2017-11-16 |
20170326191 | Molecular and Herbal Combinations for Treating Psoriasis | 2017-11-16 |
20170326192 | Molecular and Herbal Combinations for Treating Psoriasis | 2017-11-16 |
20170326193 | BUCHU PREPARATIONS | 2017-11-16 |
20170326194 | THERAPEUTIC COMPOSITIONS | 2017-11-16 |
20170326195 | A PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS | 2017-11-16 |
20170326196 | A MOUTH FRESHENER | 2017-11-16 |
20170326197 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS | 2017-11-16 |
20170326198 | LACTOCOCCUS LACTIS STRAINS FOR PRODUCING BIOACTIVE PEPTIDES HAVING ANTI-HYPERTENSIVE AND CHOLESTEROL-LOWERING EFFECTS | 2017-11-16 |